A thoracic surgeon-directed tobacco cessation intervention.
A thoracic surgeon-directed tobacco cessation intervention.
复制标题
胸外科医生指导的戒烟干预措施。
DOI：
10.1016/j.athoracsur.2009.12.046
复制
发表时间：
2010
期刊：
影响因子：
--
通讯作者：
Stukenborg,GeorgeJ
中科院分区：
文献类型：
--
作者：
Kozower,BenjaminD;Lau,ChristineL;Phillips,JenniferV;Burks,SandraG;Jones,DavidR;Stukenborg,GeorgeJ
背景胸外科医生几乎没有接受过促进戒烟的培训，尽管烟草使用对他们的病人有影响。在科学文献中，只有几个关于胸科外科医生参与戒烟努力的前瞻性报告。这项研究的目的是前瞻性地评估一家胸科门诊诊所的外科医生提供的短暂戒烟干预。方法2008年1月至12月，来自一家单一机构胸外科诊所的成年吸烟者参加了一项单臂前瞻性试点试验。患者接受了10分钟的干预，包括讨论他们戒烟的动机，提供戒烟药物，以及推广免费电话戒烟。主要结果是在3个月时禁欲。单变量Logistic回归确定了与戒烟相关的因素。结果60名合格吸烟者中有40人参加了这项研究。受试者的平均年龄和标准差为52.1±12.6岁，吸烟史为39.9±11.2年。3个月戒烟率为35%(14/40)。50%(20/40)的参与者至少使用了一种戒烟药物。只有7.5%的患者(40人中有3人)要求戒烟，但这些参与者都戒烟了。成功戒烟与癌症诊断和家中唯一吸烟者有关(优势比为4.2；95%可信区间为1.0~17.2；优势比为6.1；95%可信区间为1.4至26.3)。结论胸外科医生可以成功地实施戒烟计划，与文献报道的3个月戒烟率相比，戒烟率非常高。进一步的研究需要更大的样本量，更长的随访时间，以及更好地利用QUTOLINE。
BACKGROUNDThoracic surgeons receive little training in promoting tobacco cessation despite the impact of tobacco use on their patients. There are only a few prospective reports of tobacco cessation efforts involving thoracic surgeons in the scientific literature. The purpose of this study was to prospectively evaluate a brief tobacco cessation intervention offered by surgeons in an outpatient thoracic surgery clinic.METHODSAdult smokers from a single-institution thoracic surgery clinic were enrolled in a single-arm prospective pilot trial between January and December 2008. Patients received a 10-minute intervention including discussing their motivation for quitting, offering tobacco cessation medication, and promoting a free telephone quitline. The primary outcome was abstinence at 3 months. Univariate logistic regression identified factors associated with tobacco cessation.RESULTSForty of 60 eligible smokers enrolled in the study. The mean age and standard deviation of participants was 52.1 ± 12.6 years with a 39.9 ± 11.2 pack-year smoking history. The 3-month quit rate was 35% (14 of 40). Fifty percent (20 of 40) of participants used at least one tobacco cessation medication. Only 7.5% (3 of 40) of patients called the quitline, but each of these participants quit smoking. Successful tobacco cessation was associated with a malignant diagnosis and being the only tobacco user in the home (odds ratio, 4.2; 95% confidence interval, 1.0 to 17.2; and odds ratio, 6.1; 95% confidence interval, 1.4 to 26.3, respectively).CONCLUSIONSThoracic surgeons can successfully implement a tobacco cessation program with an excellent rate of abstinence compared with reported cessation rates at 3 months from the literature. Further investigation with a larger sample size, longer follow-up, and improved utilization of the quitline is warranted.